人乳腺癌DNA倍体和s期分数的瘤内变异

C. Arnerlöv, S. Emdin, S. Cajander, N. Bengtsson, B. Tavelin, G. Roos
{"title":"人乳腺癌DNA倍体和s期分数的瘤内变异","authors":"C. Arnerlöv, S. Emdin, S. Cajander, N. Bengtsson, B. Tavelin, G. Roos","doi":"10.1155/2001/430674","DOIUrl":null,"url":null,"abstract":"To study intratumoral DNA ploidy heterogeneity and S‐phase fraction (SPF) variability, we prospectively collected five different samples from 48 breast carcinomas and each sample was analysed separately by flow cytometry. Aneuploidy rate was 89.6% after analysis of four or five samples. DNA ploidy heterogeneity, i.e., different samples classified as either DNA euploid or DNA aneuploid in the same tumor was seen in 17%, and DNA index heterogeneity, i.e., tumor populations with different DNA indices (DIs) seen in different samples was 44%. A statistical model defining SPF heterogeneity is proposed. SPF heterogeneity as defined by us was 71%, and as expected the SPF heterogeneity rate increased significantly with increasing number of analysed samples. Four or more samples are needed to detect the most deviant (highest) SPF values. An unrecognized intratumor heterogeneity of DNA ploidy and SPF may partly explain the conflicting results reported in the literature on the above prognostic indicators.","PeriodicalId":76996,"journal":{"name":"Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology","volume":"83 1","pages":"21 - 28"},"PeriodicalIF":0.0000,"publicationDate":"2001-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"30","resultStr":"{\"title\":\"Intratumoral Variations in DNA Ploidy and S-Phase Fraction in Human Breast Cancer\",\"authors\":\"C. Arnerlöv, S. Emdin, S. Cajander, N. Bengtsson, B. Tavelin, G. Roos\",\"doi\":\"10.1155/2001/430674\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"To study intratumoral DNA ploidy heterogeneity and S‐phase fraction (SPF) variability, we prospectively collected five different samples from 48 breast carcinomas and each sample was analysed separately by flow cytometry. Aneuploidy rate was 89.6% after analysis of four or five samples. DNA ploidy heterogeneity, i.e., different samples classified as either DNA euploid or DNA aneuploid in the same tumor was seen in 17%, and DNA index heterogeneity, i.e., tumor populations with different DNA indices (DIs) seen in different samples was 44%. A statistical model defining SPF heterogeneity is proposed. SPF heterogeneity as defined by us was 71%, and as expected the SPF heterogeneity rate increased significantly with increasing number of analysed samples. Four or more samples are needed to detect the most deviant (highest) SPF values. An unrecognized intratumor heterogeneity of DNA ploidy and SPF may partly explain the conflicting results reported in the literature on the above prognostic indicators.\",\"PeriodicalId\":76996,\"journal\":{\"name\":\"Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology\",\"volume\":\"83 1\",\"pages\":\"21 - 28\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2001-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"30\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1155/2001/430674\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2001/430674","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 30

摘要

为了研究肿瘤内DNA倍体异质性和S期分数(SPF)变异性,我们前瞻性地从48例乳腺癌中收集了5个不同的样本,每个样本分别通过流式细胞术进行分析。分析4 ~ 5份样本后,非整倍性率为89.6%。DNA倍性异质性,即不同样本在同一肿瘤中被分类为DNA整倍体或DNA非整倍体的占17%,DNA指数异质性,即不同样本中DNA指数(DIs)不同的肿瘤群体占44%。提出了SPF异质性的统计模型。我们定义的SPF异质性为71%,正如预期的那样,随着分析样本数量的增加,SPF异质性率显著增加。需要四个或更多的样本来检测最偏离(最高)的SPF值。未被认识到的肿瘤内DNA倍性和SPF的异质性可能部分解释了上述预后指标在文献中报道的相互矛盾的结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Intratumoral Variations in DNA Ploidy and S-Phase Fraction in Human Breast Cancer
To study intratumoral DNA ploidy heterogeneity and S‐phase fraction (SPF) variability, we prospectively collected five different samples from 48 breast carcinomas and each sample was analysed separately by flow cytometry. Aneuploidy rate was 89.6% after analysis of four or five samples. DNA ploidy heterogeneity, i.e., different samples classified as either DNA euploid or DNA aneuploid in the same tumor was seen in 17%, and DNA index heterogeneity, i.e., tumor populations with different DNA indices (DIs) seen in different samples was 44%. A statistical model defining SPF heterogeneity is proposed. SPF heterogeneity as defined by us was 71%, and as expected the SPF heterogeneity rate increased significantly with increasing number of analysed samples. Four or more samples are needed to detect the most deviant (highest) SPF values. An unrecognized intratumor heterogeneity of DNA ploidy and SPF may partly explain the conflicting results reported in the literature on the above prognostic indicators.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信